NCT02080650View on ClinicalTrials.gov

Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

May 19, 2016

Study Completion Date

July 19, 2016

Conditions
Prostate CancerRenal Cell CarcinomaBladder CancerColorectal CancerGastric CancerPancreatic CancerNon-small Cell Lung CancerAdvanced MET Amplified Solid Tumor
Interventions
DEVICE

Mesenchymal-marker based ferrofluid (c-MET)

DEVICE

Epithelial cell adhesion molecule (EpCAM) ferrofluid

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

Janssen Diagnostics, LLC
All Listed Sponsors
collaborator

Prostate Cancer Foundation

OTHER

collaborator

Janssen Diagnostics, LLC

INDUSTRY

lead

Duke University

OTHER